Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.523
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.891
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.101
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.796
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.124
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000588
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0945
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Indirect Calorimetry / Heat Production (Metabolic Rate)
|
HOM
|
228f:522m
|
|
|
NotProcessed |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0139
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0388
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
228f:522m
|
|
|
NotProcessed |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.816
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0940
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0251
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
20f:40m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
15f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0820
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.428
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.726
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
4f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000893
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.273
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.361
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
4f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.696
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.121
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.376
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.469
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
4f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.114
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.685
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
4f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.168
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.354
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:172m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.341
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.803
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00779
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.622
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
4f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00567
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0631
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0256
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.274
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.374
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.183
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.151
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.000707
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.739
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.903
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
4f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.104
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.324
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:172m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Dexa-scan analysis / Fat Mass
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
2.36×10-06
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.878
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.921
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.262
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.00886
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.203
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00486
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0562
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.114
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:35m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
f:3m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
5.36×10-05
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
1.24×10-05
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.762
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0733
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
4f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.335
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:172m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Dysmorphology / Body fat distribution
|
HOM
|
8f:8m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Indirect Calorimetry / Cumulative food intake
|
HOM
|
228f:522m
|
|
|
NotProcessed |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0582
|
Successful |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
4f:m
|
|
|
NotProcessed |
Dlg2tm1Dsb
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
4f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.601
|
Successful |
Dlg2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.957
|
Successful |